The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LUMINA: A prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T1N0 luminal A breast cancer (BC).
Timothy Joseph Whelan
Research Funding - Exact Sciences (Inst)
Sally Smith
Consulting or Advisory Role - Genzyme
Torsten O. Nielsen
Stock and Other Ownership Interests - Bioclassifier
Consulting or Advisory Role - Veracyte
Patents, Royalties, Other Intellectual Property - PAM50 Breast Cancer Classifier
Sameer Parpia
Consulting or Advisory Role - Baylis Medical
Anthony W. Fyles
Research Funding - Exact Sciences (Inst)
Anita Bane
No Relationships to Disclose
Fei-Fei Liu
No Relationships to Disclose
Laval Grimard
No Relationships to Disclose
Christiaan Stevens
No Relationships to Disclose
Julie Bowen
No Relationships to Disclose
Sawyna Provencher
No Relationships to Disclose
Eileen Rakovitch
Honoraria - AstraZeneca
Research Funding - Genomic Health International
Valerie Theberge
No Relationships to Disclose
Anna Marie Mulligan
Honoraria - AstraZeneca (I)
Mohamed A. Akra
No Relationships to Disclose
K. David Voduc
No Relationships to Disclose
Tarek Hijal
Leadership - Multiwave Technologies
Consulting or Advisory Role - L'Oreal
Speakers' Bureau - Pfizer
Research Funding - Novartis; Roche Canada
Ian S. Dayes
Honoraria - Abbvie; Verity Pharmaceuticals
Gregory Russell Pond
Employment - Roche Canada (I)
Stock and Other Ownership Interests - Roche Canada (I)
Honoraria - AstraZeneca; AstraZeneca
Consulting or Advisory Role - Merck; Profound Medical; Takeda
Mark Norman Levine
No Relationships to Disclose